Although the case mix of patients and setting of studies may explain some of these variations, most can be accounted for by the differing criteria used to diagnose pneumonia between studies. The diagnosis of nosocomial (ventilator acquired) pneumonia remains a challenge and the source of considerable debate.34 This uncertainty has important consequences for both clinical research and practice. For example, whether mortality is the appropriate end point to test the efficacy of preventive measures of ventilator associated pneumonia such as selective decontamination5
is unknown, and depends on the expected impact of pneumonia on the outcome. Similarly, whether reliable and useful information can be gained from studies of risk factors of pneumonia is open to question if half of the population studied does not actually have the disease but has only bronchitis or bacterial colonisation. In addition, we may be unnecessarily administering antibiotics to patients suspected of ventilator acquired pneumonia, thus encouraging the development of antibiotic resistance in the hospital environment. Alternatively, we may be delaying treatment by using over restrictive diagnostic criteria, thus potentially increasing the morbidity of the infection. Obviously, some consensus has to be reached on the appropriate means by which to recognise and diagnose acquired pneumonia.6
While traditional clinical criteria (presence of fever, purulent sputum and leucocytosis, together with the appearance of new radiographic infiltrates) have an acceptable accuracy for diagnosing nosocomial pneumonia in the nonintubated patient, these criteria have been repeatedly shown to be both insensitive and non-specific in mechanically ventilated patients.78 This is particularly true in patients with pre-existing pulmonary abnormalities and in those with diffuse lung injury.79"-1 Meduri et al, for example, found that a thorough evaluation of fever in 50 mechanically ventilated patients suspected of pneumonia resulted in only 42% of them being diagnosed as actually having pneumonia, with other causes of fever and/or pulmonary densities in the others.'2 Clinical and radiographic criteria must therefore be complemented by microbiological criteria. Having said this, it does not solve the problem, as it leads to even more confusion than the issue of clinical criteria -namely, which sampling technique should be used for obtaining microbiological information, and how reliable are these techniques in mechanically ventilated patients? Unfortunately, much of the recent literature has provided more confusion than help in clarifying these issues.
Because of the widespread colonisation of the airways, including the trachea and central airways in intubated patients,'3 two steps have been taken in devising methods for sampling lower respiratory secretions: (1) sampling via protected devices to minimise contamination when the device is passed through the endotracheal tube and upper airways; and (2) the use of quantitative cultures to help distinguish between infecting and contaminating or colonising organisms. A number of techniques with various degrees of sophistication along these lines have been proposed in the past 10 years, including the protected (doublesheathed) specimen brush, the protected (single-sheathed) catheter, protected mini-bronchoalveolar lavage, and standard (protected or not) bronchoalveolar lavage; all except standard bronchoalveolar lavage have been performed "blindly" or via fibreoptic bronchoscopy.8' 1-6 Whatever the technique used, quantitative cultures appear to be mandatory to ensure the discriminatory power of the sample." Some recent studies, for example, have compared the diagnostic value of endotracheal aspirates and new sampling techniques.'718 They all confirm the high sensitivity of an endotracheal aspirate, but also its unacceptably low specificity unless quantitative cultures are performed; however, a very high diagnostic threshold (> 106 cfu/ml) should then be selected which results in a loss of diagnostic sensitivity. It is illusory to expect any single diagnostic test to have 100% sensitivity and specificity, and the choice of a particular technique (or even of a combination of techniques) may depend on whether the emphasis is put on sensitivity or on specificity.
How much more accurate than traditional sampling techniques such as the simple endotracheal aspirate are these new techniques, and how do they compare with each other? There are two ways of approaching this problem: one is to compare the yield of one (experimental) technique with another, taken as the standard. Another more scientifically valid approach -because there is no widely accepted reference sampling technique -is to evaluate the information given by one or several sampling methods while the presence or absence of pneumonia is ascertained by an independent test. Needless to say, there are many more studies corresponding to the first design than to the second because the only test that is widely accepted as definitive is histological demonstration of the pneumonia.6 There are, however, many practical problems here which limit one to general inferences, as histological examination can only be performed at an immediate necropsy where lung cultures can also be obtained. This limits the patients studied to those who have severe underlying disease and/or pneumonia, and the results may not be applicable to those with less severe or advanced forms of the disease. There are also major problems with the interpretation of both the pathological and microbiological data obtained from a necroscopic study in patients who have received mechanical ventilation for several days as they often have a history of prior lung disease which may interfere with the interpretation of the pathological findings. In addition, and more importantly, many experience some acute lung injury during the mechanical ventilation. Histological changes consistent with pneumonia found at necroscopic examination after several days of mechanical ventilation may be extremely difficult to ascribe to a current episode of active lung infection, or to a prior or partially resolved episode. A 
